Spiral Therapeutics
delivering therapies for inner ear disorders
delivering therapies for inner ear disorders
Spiral Therapeutics is a clinical stage company founded in 2016 with the mission of delivering therapies for inner ear disorders. The company operates in the Biotechnology, Health Care, and Pharmaceutical industries, with its headquarters located in the United States.
The latest milestone for Spiral Therapeutics was a Venture Round investment on 30 August 2023, with funding secured from Esperante Ventures and Ferring Ventures.
This recent investment not only reflects confidence in the potential of the company's innovative therapies but also signifies a significant step forward in the development and commercialization of treatments for inner ear disorders. With the support of esteemed investors, Spiral Therapeutics is well-positioned to advance its mission and make a meaningful impact on the healthcare industry.
| Funding Stage | Amount | No. Investors | Investors | Date |
|---|---|---|---|---|
| Venture Round | Unknown | 2 |
|
30 Aug 2023 |
| Venture Round | $8.25M | 3 |
|
09 Jan 2023 |
| Series A | $5.60M | 4 |
|
12 Dec 2018 |
| Convertible Note | $1.63M | - | 01 Feb 2018 | |
| Angel Round | $3.00M | - | 31 Mar 2017 |
No recent news or press coverage available for Spiral Therapeutics.
We care about your data, and we'd love to use cookies make your experience better.
